LABORATOIRES THEA
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- -
- Established
- 1994-01-01
- Employees
- -
- Market Cap
- -
Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients
- First Posted Date
- 2010-07-02
- Last Posted Date
- 2015-01-22
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 404
- Registration Number
- NCT01156012
- Locations
- 🇫🇷
Medical Director, Clermont-Ferrand, France
Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients.
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 150
- Registration Number
- NCT01155219
Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases
Phase 4
Completed
- Conditions
- First Posted Date
- 2010-03-24
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 30
- Registration Number
- NCT01091311
- Locations
- 🇫🇷
C.H.N.O des XV-XX, Paris, France
🇫🇷Hôpital Bichat - Claude Bernard, Paris, France
🇫🇷Hôpital Gabriel Montpied, Clermont-Ferrand, France
Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis
- First Posted Date
- 2010-03-18
- Last Posted Date
- 2014-11-04
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 93
- Registration Number
- NCT01089608
- Locations
- 🇫🇷
C.H.N.O des XV-XX, Paris, France
Clinical Safety Study on an Eyelid Warming Device to Evaluate the Eyelid and Cornea Temperature in Healthy Volunteers
- First Posted Date
- 2010-03-15
- Last Posted Date
- 2012-01-31
- Lead Sponsor
- Laboratoires Thea
- Target Recruit Count
- 25
- Registration Number
- NCT01086943
- Locations
- 🇬🇧
School of Optometry & Vision Sciences, Cardiff, United Kingdom
Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-07-27
- Last Posted Date
- 2006-07-27
- Lead Sponsor
- Laboratoires Thea
- Registration Number
- NCT00357773
Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis
Phase 4
Completed
- Conditions
- First Posted Date
- 2006-07-27
- Last Posted Date
- 2006-07-27
- Lead Sponsor
- Laboratoires Thea
- Registration Number
- NCT00357019
Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-07-27
- Last Posted Date
- 2006-07-27
- Lead Sponsor
- Laboratoires Thea
- Registration Number
- NCT00357201
Safety and Ocular Pharmacokinetics After 1 Drop of T1225 0.5, 1 and 1.5% in 48 Healthy Volunteers
Phase 1
Completed
- Conditions
- First Posted Date
- 2006-07-27
- Last Posted Date
- 2006-07-27
- Lead Sponsor
- Laboratoires Thea
- Registration Number
- NCT00357539
- Locations
- 🇫🇷
Unité de Pharmacologie Clinique, Clermont Ferrand, France
Study of the Ocular Safety After Repeated Instillations of T1225 1% or 1.5% Eye Drops in Healthy Volunteers
Phase 1
Completed
- Conditions
- First Posted Date
- 2006-07-27
- Last Posted Date
- 2006-07-27
- Lead Sponsor
- Laboratoires Thea
- Registration Number
- NCT00357383
© Copyright 2024. All Rights Reserved by MedPath